Format

Send to

Choose Destination
J Med Chem. 2015 Jan 8;58(1):72-95. doi: 10.1021/jm501212r. Epub 2014 Dec 8.

Inhibitors of c-Jun N-terminal kinases: an update.

Author information

1
Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmaceutical Sciences, Eberhard Karls Universität Tübingen , Auf der Morgenstelle 8, 72076 Tübingen, Germany.

Abstract

The c-Jun N-terminal kinases (JNKs) are serine/threonine kinases implicated in the pathogenesis of various diseases. Recent advances in the development of novel inhibitors of JNKs will be reviewed. Significant progress in the design of JNK inhibitors displaying selectivity versus other kinases has been achieved within the past 4 years. However, the development of isoform selective JNK inhibitors is still an open task.

PMID:
25415535
DOI:
10.1021/jm501212r
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center